Dr. Peter Schneider of University of California San Francisco discusses selecting TCAR vs. CEA for the treatment of carotid artery disease. The TransCarotid Artery Revascularization (TCAR) procedure is a clinically proven, minimally invasive treatment option for carotid artery disease.

If you have any questions about the TCAR® system, please comment below or contact us at
http://silkroadmed.com/contactus/

Follow us on our social media channels:
Facebook –   / silkroadmed  
Twitter –   / silkroadmed  
LinkedIn –   / silk.  .

TransCarotid Artery Revascularization (TCAR) is a clinically proven procedure combining surgical principles of neuroprotection with minimally invasive endovascular techniques to treat blockages in the carotid artery at risk of causing a stroke. The ENROUTE Transcarotid Stent is intended to be used in patients at high risk and standard risk for adverse events from CEA, in conjunction with the ENROUTE Transcarotid Neuroprotection System (NPS). The ENROUTE Transcarotid NPS is a first in class device used to directly access the common carotid artery and initiate high rate temporary blood flow reversal to protect the brain from stroke while delivering and implanting the ENROUTE Transcarotid Stent.

Caution: Federal (US) law restricts this device to sale by or on the order of a physician. Please refer to Instructions for Use for indications, contraindications, warnings and precautions.

For essential prescribing information, please visit http://silkroadmed.com/ifu/.

Carotid Artery Disease and Stroke
Every year, 15 million people worldwide suffer a stroke. Nearly 6 million die and another 5 million are left permanently disabled. Stroke is the second leading cause of disability globally. Ischemic strokes account for 8090 percent of strokes, and an estimated 2030 percent of these are caused by disease in the carotid arteries that carry blood to the brain. If left untreated, these blockages can fragment, flow to the brain and lead to a potentially disabling stroke, also known as a “brain attack.”

For more information about carotid artery disease and the risks involved with any intervention (e.g. bleeding, death, myocardial infarction, restenosis, stroke, TIA, vessel dissection, vessel occlusion, etc.), please visit: https://protectionfromstroke.com/

AP365.A

How Do Surgeons Decide Which Carotid Procedure to Perform?
Peter Schneider MD: When I first started with TCAR, I looked at TCAR as an option for patients who couldn't have carotid endarterectomy. And now that the data has accumulated showing that TCAR, at least the data we have so far, it's really looking like it's as good in terms of the risk of stroke and that kind of thing. The things we really worry about and we really don't want to have happen when we're fixing one of these arteries. And so as the data has improved, my way of looking at it has kind of flipflopped. I've looked at TCAR as more of a primary therapy and look for reasons why I shouldn't do TCAR and then would end up with endarterectomy.